Multidrug-resistant Organisms (MDROs) in Patients with Subarachnoid Hemorrhage (SAH)

Overview

Journal Sci Rep

Specialty Science

Date 2021 Apr 16

PMID 33859304

Citations 4

Authors

Ha-Young Rhim

Sae-Yeon Won

Sepide Kashefiolasl

Nina Brawanski

Elke Hattingen

Joachim Berkefeld

Volker Seifert

Juergen Konczalla

Affiliations

Soon will be listed here.

Abstract

Patient care in a neurointensive care unit (neuro-ICU) is challenging. Multidrug-resistant organisms (MDROs) are increasingly common in the routine clinical practice. We evaluated the impact of infection with MDROs on outcomes in patients with subarachnoid hemorrhage (SAH). A single-center retrospective analysis of SAH cases involving patients treated in the neuro-ICU was performed. The outcome was assessed 6 months after SAH using the modified Rankin Scale [mRS, favorable (0-2) and unfavorable (3-6)]. Data were compared by matched-pair analysis. Patient characteristics were well matched in the MDRO (n = 61) and control (n = 61) groups. In this center, one nurse was assigned to a two-bed room. If a MDRO was detected, the patient was isolated, and the nurse was assigned to the patient infected with the MDRO. In the MDRO group, 29 patients (48%) had a favorable outcome, while 25 patients (41%) in the control group had a favorable outcome; the difference was not significant (p > 0.05). Independent prognostic factors for unfavorable outcomes were worse status at admission (OR = 3.1), concomitant intracerebral hematoma (ICH) (OR = 3.7), and delayed cerebral ischemia (DCI) (OR = 6.8). Infection with MRDOs did not have a negative impact on the outcome in SAH patients. Slightly better outcomes were observed in SAH patients infected with MDROs, suggesting the benefit of individual care.

Citing Articles

The Role of Nursing Care in the Management of Patients with Traumatic Subarachnoid Hemorrhage.

Miao Q, Yan Y, Zhou M, Sun X Galen Med J. 2024; 12:e3013.

PMID: 38774855 PMC: 11108670. DOI: 10.31661/gmj.v12i0.3013.

Clinical epidemiology and case fatality due to antimicrobial resistance in Germany: a systematic review and meta-analysis, 1 January 2010 to 31 December 2021.

Rodenbeck M, Ayobami O, Eckmanns T, Pletz M, Bleidorn J, Markwart R Euro Surveill. 2023; 28(20).

PMID: 37199987 PMC: 10197495. DOI: 10.2807/1560-7917.ES.2023.28.20.2200672.

Rate of Multidrug-resistance to Antimicrobial Drugs in Patients in Pediatric Neurointensive Care.

Patel S, Prabhakar H, Kapoor I Indian J Crit Care Med. 2023; 27(1):67-72.

PMID: 36756473 PMC: 9886037. DOI: 10.5005/jp-journals-10071-24377.

Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia.

Idigo A, Wells J, Brown M, Wiener H, Griffin R, Cutter G Antimicrob Resist Infect Control. 2022; 11(1):95.

PMID: 35836272 PMC: 9284849. DOI: 10.1186/s13756-022-01137-4.

References

van Duijn P, Dautzenberg M, Oostdijk E . Recent trends in antibiotic resistance in European ICUs. Curr Opin Crit Care. 2011; 17(6):658-65. DOI: 10.1097/MCC.0b013e32834c9d87. View

Troche G, Joly L, Guibert M, Zazzo J . Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey. Infect Control Hosp Epidemiol. 2005; 26(2):161-5. DOI: 10.1086/502521. View

Rivera-Lara L, Ziai W, Nyquist P . Management of infections associated with neurocritical care. Handb Clin Neurol. 2017; 140:365-378. DOI: 10.1016/B978-0-444-63600-3.00020-9. View

Jain S, Khety Z . Changing antimicrobial resistance pattern of isolates from an ICU over a 2 year period. J Assoc Physicians India. 2012; 60:27-8, 33. View

Blot S, Vandewoude K, Blot K, Colardyn F . Prevalence and risk factors for colonisation with gram-negative bacteria in an intensive care unit. Acta Clin Belg. 2000; 55(5):249-56. DOI: 10.1080/17843286.2000.11754307. View

Zhang Y, Zhou H, Cai H, Yang Q, Shen Q, Shen Y . [Analysis of clinical manifestations and risk factors of mortality in Acinetobacter baumannii bloodstream infection]. Zhonghua Nei Ke Za Zhi. 2016; 55(2):121-6. DOI: 10.3760/cma.j.issn.0578-1426.2016.02.011. View

Deptula A, Gospodarek E . Reduced expression of virulence factors in multidrug-resistant Pseudomonas aeruginosa strains. Arch Microbiol. 2009; 192(1):79-84. DOI: 10.1007/s00203-009-0528-1. View

Rosengart A, Schultheiss K, Tolentino J, Loch Macdonald R . Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007; 38(8):2315-21. DOI: 10.1161/STROKEAHA.107.484360. View

Zahar J, Garrouste-Orgeas M, Vesin A, Schwebel C, Bonadona A, Philippart F . Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events. Intensive Care Med. 2013; 39(12):2153-60. DOI: 10.1007/s00134-013-3071-0. View

10.

Pegoli M, Mandrekar J, Rabinstein A, Lanzino G . Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2014; 122(2):414-8. DOI: 10.3171/2014.10.JNS14290. View

11.

Eberle B, Schnuriger B, Putty B, Barmparas G, Kobayashi L, Inaba K . The impact of Acinetobacter baumannii infections on outcome in trauma patients: a matched cohort study. Crit Care Med. 2010; 38(11):2133-8. DOI: 10.1097/CCM.0b013e3181f17af4. View

12.

Maslikowska J, Walker S, Elligsen M, Mittmann N, Palmay L, Daneman N . Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. J Hosp Infect. 2015; 92(1):33-41. DOI: 10.1016/j.jhin.2015.10.001. View

13.

Celen M, Tamam Y, Hosoglu S, Ayaz C, Geyik M, Apak I . Multiresistant bacterial colonization due to increased nurse workload in a neurology intensive care unit. Neurosciences (Riyadh). 2012; 11(4):265-70. View

14.

Fisher C, Kistler J, Davis J . Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980; 6(1):1-9. DOI: 10.1227/00006123-198001000-00001. View

15.

Vardakas K, Matthaiou D, Falagas M, Antypa E, Koteli A, Antoniadou E . Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit. J Infect. 2014; 70(6):592-9. DOI: 10.1016/j.jinf.2014.11.003. View

16.

Sun Z, Jiao X, Peng Q, Jiang F, Huang Y, Zhang J . Antibiotic resistance in Pseudomonas aeruginosa is associated with decreased fitness. Cell Physiol Biochem. 2013; 31(2-3):347-54. DOI: 10.1159/000343372. View

17.

Loch Macdonald R . Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2013; 10(1):44-58. DOI: 10.1038/nrneurol.2013.246. View

18.

Suarez C, Pena C, Gavalda L, Tubau F, Manzur A, Dominguez M . Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection. Int J Infect Dis. 2010; 14 Suppl 3:e73-8. DOI: 10.1016/j.ijid.2009.11.019. View

19.

Green D, Burns J, DeFusco C . ICU management of aneurysmal subarachnoid hemorrhage. J Intensive Care Med. 2012; 28(6):341-54. DOI: 10.1177/0885066611434100. View

20.

Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O . Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2011; 18(1):54-60. DOI: 10.1111/j.1469-0691.2011.03478.x. View